PRIMARY
EFFUSION LYMPHOMA (PEL) Aetiology : it occurs in patients with
HIV
infection
HHV-8 / KSHV+
immunoblasts with plasmacytoid cytoplasm. Most PELs have concomitant HHV-4
/ EBV
infection and these viral double positive cells harbour mutated rearranged
Ig genes, suggesting that they originate from germinal centre or post-germinal
centre B-cells, suggesting that EBV is an important pathogenetic cofactor,
although other as yet unidentified cofactors, such as cellular genetic
alterations, are also likely to play a role. Within the KSHV+
PELs, the effect of EBV is more subtle but nevertheless clearref
HHV-4 / EBV+
PELs (most) are derived from germinal centre or post-germinal centre B-cells
EBV- PELs may originate from either germinal/post-germinal centre
or naive B-cellsref
lymphomatous effusions that lack KSHV also occur; these are frequently
EBV associated in the setting of HIV infection. Many genes, including cell
cycle and signal transduction regulators, are differentially expressed
between KSHV+ PELs and KSHV- lymphomatous effusions
and also between KSHV+, EBV+ and KSHV+,
EBV- PELs. KSHV plays an important role in the pathogenesis
of PELs, as its presence selects for a very distinct cellular gene expression
category and a clearly different lymphoma typeref.
Symptoms & signs : lymphomatous effusions
primarily body cavities and occasionally extranodal sites without the presence
of a solid tumor
Laboratory examinations : the tumor cells
usually do not express immunoglobulin (Ig) and B-cell markers but express
syndecan-1 (CD138)ref
and harbor hypermutated rearranged immunoglobulin genesref,
suggesting that they originate from germinal center or postgerminal center
B cellsref